Related Experiment Video

Updated: Feb 8, 2026

Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling
06:24

Generation of Human Microglia to Combine Them with Retinal Organoids for Improved Disease Modeling

Published on: July 26, 2024

2.0K

Microglia Activation and Immunomodulatory Therapies for Retinal Degenerations

Khalid Rashid1, Anne Wolf1, Thomas Langmann1,2

  • 1Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.

Frontiers in Cellular Neuroscience
|July 7, 2018
PubMed

Insights

Targeting microglial inflammation with translocator protein 18 kDa (TSPO) ligands and interferon beta (IFN-β) can protect vision in retinal diseases. These interventions may reduce photoreceptor cell death and preserve retinal integrity by modulating microgliosis.

Area of Science:

  • Neuroscience
  • Immunology
  • Ophthalmology

Background:

  • Chronic inflammation is central to retinal degenerative diseases and vision loss.
  • Microglia, the resident immune cells of the retina, orchestrate inflammatory responses.
  • Overreactive microglia contribute to photoreceptor cell death in retinal pathologies.

Purpose of the Study:

  • To explore therapeutic strategies targeting microglial pro-inflammatory and pro-oxidative functions.
  • To highlight the beneficial effects of translocator protein 18 kDa (TSPO) ligands and interferon beta (IFN-β) in retinal diseases.
  • To discuss the mechanisms by which TSPO ligands and IFN-β modulate microgliosis.

Main Methods:

  • Review of literature on microglial activation in retinal pathophysiology.
  • Analysis of studies investigating TSPO ligands and IFN-β in models of retinal disease.
  • Discussion of the molecular pathways involved in microglial modulation.

Main Results:

  • Ligands targeting TSPO show promise in modulating microglial responses.
  • Interferon beta (IFN-β) demonstrates potential in mitigating retinal inflammation.
  • Both interventions may attenuate photoreceptor cell loss and preserve retinal structure.

Conclusions:

  • Modulating microglial activity via TSPO ligands and IFN-β offers a potential therapeutic avenue for retinal degenerative diseases.
  • Targeting these pathways could preserve vision by reducing inflammation and protecting photoreceptors.
  • Further research is warranted to elucidate the precise mechanisms and clinical applications.
Keywords:
TSPOinterferon-betamicrogliaphotoreceptorsretinal degeneration

More Related Videos

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish06:27

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish

Published on: October 27, 2017

10.4K
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.8K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
450
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
550
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
728
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
302